Carthera | 6,995 followers on LinkedIn. Advanced Brain Therapy | Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range o...

Ancora is a search tool that enables cancer patients to find relevant clinical trials in minutes. Radiopharmaceutical trial finder, nuclear medicine.

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

YouTube video by Med Tech Gurus

YouTube video by Brain Wellness NP

SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...

Affidato allo Iov il coordinamento di un innovativo progetto internazionale per rendere molto più efficaci le terapie per contrastare questo aggressivo tumore cerebrale

New research shows how glioblastoma cells infiltrate the brain and which key genes drive the invasion, paving the way to new treatments.

Purdue University College of Veterinary Medicine researchers are taking an innovative approach to studying Alzheimer’s disease. Dr. Ranjie Xu, an assistant professor in the Department of Basic Medical...

Lynn lives an active lifestyle as an owner of her own luxury traveling tours business. But when she got back from a corporate cruise in November of 2023, she started to feel sick every day. Lynn was q...

YouTube video by Michael and Mom Inspire

YouTube video by Battlecorn Care Packages

This episode includes a fascinating interview with a researcher in ultrasound, Dr. Michael Canney who is an acoustics researcher the chief scientific officer at a French company named Carthera (https:...

VIDÉO - Le professeur Olivier Chinot, neuro-oncologue à l'APHM, présente un essai clinique innovant pour traiter le glioblastome, un cancer du cerveau.

Despite recent advancements in neuro-oncology, glioblastoma remains one of the cancers with the poorest prognosis. Tumor recurrence and progression are driven by tumor stem cells and a high mutational...

NewYork-Presbyterian neurosurgeon Dr. Brian Gill describes the SONOBIRD trial, which tests a new implantable ultrasound device that may improve drug delivery to the brain to treat glioblastoma.

A Grammy-winning singer who was diagnosed in December 2023 with glioblastoma—the most aggressive and rapidly progressing type of brain cancer—began showing signs that something was wrong the previous ...

Carthera’s Sonocloud-9 could eliminate challenges presented by the blood-brain barrier

Save the Date: ANNS Annual Meeting! The premier event for neurosurgeons and neurosurgical medical professionals in Boston, April 25-28, 2025.

Researchers from the University of Minnesota are developing a cell therapy that would combat Alzheimer’s disease using strategies used in blood cancer treatment, according to a press release. The cell...

Save the Date: ANNS Annual Meeting! The premier event for neurosurgeons and neurosurgical medical professionals in Boston, April 25-28, 2025.

YouTube video by Carthera

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical dat...

Save the Date: ANNS Annual Meeting! The premier event for neurosurgeons and neurosurgical medical professionals in Boston, April 25-28, 2025.

Scholar-Elect Sarah Nicholls talks about her research on the protein tau and the role it might play in Alzheimer's Disease

Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some Alzheimer’s disease patients for up to eight weeks in a preliminary trial led by U...

Henry Scowcroft looks at a pioneering new clinical platform trial set to offer more options to UK glioblastoma patients and kick-start progress

YouTube video by Al Musella

ETH Zurich researchers have revealed how ultrasound-activated microbubbles create liquid jets that pierce blood vessel walls, allowing drugs to enter the brain. Their findings clarify the mechanisms b...

Repurposed drugs provide a rich source of potential therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders (NDD). In this review, the authors discuss the advantages and challenge...

Northwestern Medicine investigators have discovered unique genetic and structural changes in endothelial cells in the brain after disrupting the blood-brain barrier, which may inform new therapeutic t...

Key Points Almost a year ago in February 2024, Carthera launched its large comparative SonoCloud® Blood-Brain Barrier Opening for Recurrent Disease (SONOBIRD*) clinical trial (NCT 05902169) in Europe ...

Focused ultrasound presentations included both clinical and preclinical efforts to improve the treatment of brain tumors.

Focused ultrasound presentations included both clinical and preclinical efforts to improve the treatment of brain tumors.

Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease.

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells.